AU3973793A - Method of treating cancer - Google Patents

Method of treating cancer

Info

Publication number
AU3973793A
AU3973793A AU39737/93A AU3973793A AU3973793A AU 3973793 A AU3973793 A AU 3973793A AU 39737/93 A AU39737/93 A AU 39737/93A AU 3973793 A AU3973793 A AU 3973793A AU 3973793 A AU3973793 A AU 3973793A
Authority
AU
Australia
Prior art keywords
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39737/93A
Other languages
English (en)
Inventor
Bruce R. Bistrian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
New England Deaconess Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Deaconess Hospital filed Critical New England Deaconess Hospital
Publication of AU3973793A publication Critical patent/AU3973793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU39737/93A 1992-04-27 1993-04-05 Method of treating cancer Abandoned AU3973793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87401592A 1992-04-27 1992-04-27
US874015 1992-04-27

Publications (1)

Publication Number Publication Date
AU3973793A true AU3973793A (en) 1993-11-29

Family

ID=25362796

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39737/93A Abandoned AU3973793A (en) 1992-04-27 1993-04-05 Method of treating cancer

Country Status (2)

Country Link
AU (1) AU3973793A (fr)
WO (1) WO1993021939A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231190B2 (en) * 2000-12-23 2005-11-03 Creighton University Methods for inducing apoptosis and inhibiting proliferation in cancer cells
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
CA2542834C (fr) 2003-10-21 2012-04-24 Igf Oncology, Llc Conjugues ou co-administration de ligands du recepteur igf-1 et d'agents chimiotherapeutiques anticancereux
WO2005072292A2 (fr) * 2004-01-24 2005-08-11 Hugh Mctavish Procedes d'amelioration de radiotherapie
CA2582552A1 (fr) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxines et radionucleides couples aux ligands du recepteur igf-1 pour le traitement d'un cancer
WO2010146059A2 (fr) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarqueurs pour une thérapie par inhibiteur d'igf-1r
CA2936675C (fr) 2014-01-12 2023-06-27 Igf Oncology, Llc Proteines de fusion contenant un facteur-1 de croissance de type insuline et un facteur de croissance epidermique et leurs variantes, et leurs utilisations
EP3630195A4 (fr) 2017-05-21 2021-03-24 IGF Oncology, LLC Conjugué de facteur de croissance insuline-like - produit chimiothérapeutique pour le traitement du syndrome myélodysplasique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081105A (en) * 1988-01-15 1992-01-14 New England Deaconess Hospital Corporation Method of treating cancer using structured lipids
US4906664A (en) * 1988-01-15 1990-03-06 New England Deaconess Hospital Corporation Nutritional supplement for treatment of cancer cachexia

Also Published As

Publication number Publication date
WO1993021939A1 (fr) 1993-11-11

Similar Documents

Publication Publication Date Title
AUPN271295A0 (en) Method of treatment
AU6407094A (en) Method of treating tumors with antibodies
AU3730093A (en) Methods of treating diabetes
AU3975993A (en) Method and composition for treating acne
AU617252B2 (en) Method of treating tinea
AU2685892A (en) Method of treating blood
AU4511493A (en) Microwave treatment apparatus
AU3973793A (en) Method of treating cancer
AU1500795A (en) Method of treating fine ore
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU7770991A (en) Method and composition for the treatment of cancer
GB9218027D0 (en) Novel method of treatment
AU3720293A (en) Method and compositions for treating acne
AU3177893A (en) Method for diagnosing and treating cancer
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
ZA936166B (en) Methods of treating cancer
AU2337997A (en) Method of treating cancer using c-26 modified bryostatin
GB9202196D0 (en) Method of treatment
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU2348492A (en) Method of treating asthma
AU663369B2 (en) Method of treating GAR-transformylase-dependent tumors
AU6358994A (en) Method of cancer treatment
AU4119993A (en) Heteroaroyl-10-deazaaminopterins for treatment of inflammation
GB9201391D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment